March 20, 2018 / 8:19 AM / a month ago

BRIEF-Motif Bio Announces Update On NDA Submission For Iclaprim

March 20 (Reuters) - Motif Bio Plc:

* MOTIF BIO UPDATE ON NDA SUBMISSION FOR ICLAPRIM

* ‍CO HAS DECIDED THAT IN ORDER TO ENSURE A COMPLETE AND HIGH QUALITY SUBMISSION, IT WOULD BE PRUDENT TO TAKE ADDITIONAL TIME​

* ‍NOW EXPECTS THAT NDA WILL BE SUBMITTED TO FDA DURING Q2 OF 2018​ Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below